Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.15 +5.50%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
- XP Inc. (XP) Tops Q2 EPS by 8c
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
